Balase, Bby. Boy .

HRN: 22-06-90  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/20/2022
AMPICILLIN 250MG (VIAL)
10/20/2022
10/28/2022
IVTT
100mg
Q12
PSNB
Waiting Final Action 
10/20/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/20/2022
10/27/2022
IVTT
30mg
Q24
PSNB
Waiting Final Action 
10/22/2022
CEFOTAXIME 500MG (VIAL)
10/22/2022
10/29/2022
IVTT
200mg
Q12
Psnb
Waiting Final Action 
10/24/2022
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
10/24/2022
10/31/2022
IVTT
24 Mg, As LD Then 12 Mg
Q24
PSNB
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: